Target intelligence / Profile preview

KIF25 antisense RNA 1 (KIF25-AS1)

Target: KIF25-AS1
Molecular classification: Long noncoding RNA (lncRNA), Antisense RNA, Other (non-protein coding)

Overview

KIF25 antisense RNA 1 (KIF25-AS1) is a long noncoding RNA transcribed from the antisense DNA strand of the KIF25 gene. As an antisense RNA, it does not encode a protein; instead, it most likely functions by regulating gene expression locally (cis effects) or potentially at distant loci (trans effects), through mechanisms such as transcriptional interference, modulation of chromatin structure, or direct interaction with regulatory proteins. While other antisense lncRNAs play prominent roles in disease, especially cancer, current research does not identify KIF25-AS1 as a confirmed disease-associated molecule or a validated therapeutic target[4][2]. Generally, antisense RNAs like KIF25-AS1 are important for fine-tuning gene expression and may play roles in chromatin organization or transcriptional regulation[2], but the precise physiological and pathological functions of KIF25-AS1 remain to be elucidated.

Other names: C6orf54NCRNA00300HGC6.1.1HGC6.3Protein HGC6.1KIF25 antisense gene protein 1KIF25 antisense RNA 1 (non-protein coding)

Biological functions

Regulation of gene expression at the transcriptional and post-transcriptional levels[4]Possible involvement in chromatin remodeling and transcription interference, consistent with general mechanisms of antisense lncRNAs[2]May act in cis (locally affecting the KIF25 locus) or trans (affecting distant loci), though specific mechanistic details for KIF25-AS1 remain unclear[2]

Disease associations

Other (no well-established involvement in specific diseases; literature does not currently link KIF25-AS1 to major diseases such as cancer, inflammation, or neurodegeneration as seen with some other lncRNAs)

Beyond the preview

Go deeper on KIF25 antisense RNA 1 (KIF25-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KIF25 antisense RNA 1 (KIF25-AS1).

Explore the full profile